NASDAQ: RSLSReshape Lifesciences Inc Stock Ownership - Who owns Reshape Lifesciences?
Insider buying vs selling
Have Reshape Lifesciences Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when RSLS insiders and whales buy or sell their stock.
RSLS Shareholders
What type of owners hold Reshape Lifesciences Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Armistice Capital LLC | 1,956.81% | 14,446,692 | $36.41M | Insider |
| Yair Schneid | 333.34% | 2,461,000 | $6.20M | Insider |
| Andrew P. Rasdal | 132.59% | 978,882 | $2.47M | Insider |
| Domain Parters VII L P | 110.18% | 813,433 | $2.05M | Insider |
| Barton P. Bandy | 104.72% | 773,098 | $1.95M | Insider |
| Interwest Partners X LP | 51.50% | 380,224 | $958.16k | Insider |
| Dan W. Gladney | 38.46% | 283,922 | $715.48k | Insider |
| Lori Courtney McDougal | 34.33% | 253,429 | $638.64k | Insider |
| Gary Blackford | 34.33% | 253,429 | $638.64k | Insider |
| Arda Phd Minocherhomjee | 34.33% | 253,429 | $638.64k | Insider |
RSLS vs Medical Device Stocks
Reshape Lifesciences Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.